Surgical procedures were performed using standard 23- or 25-gauge PPV methods on a Constellation (Alcon, Inc., Ft. Worth, TX, USA) vitrectomy system and standard cannula placement 3.5 mm posterior to the limbus. Balanced salt solution (BSS-Plus; Alcon, Inc.) was used for irrigation of the eye during vitrectomy. Intraocular visualization was achieved using the OPMI Lumera 700 surgical microscope with ReSight viewing system (Carl Zeiss Meditec, Inc., Dublin, CA, USA) or a similar system. A posterior vitreous detachment was induced if not already present in all cases. A 41-gauge subretinal infusion cannula (MedOne Surgical, Inc., Sarasota, FL, USA) was used to induce the focal RD starting in the inferior or superior edge of the SMH. In all cases, the procedure included a subretinal injection of tPA (25–50 μg/0.1 mL) sufficient to detach the complete area of the SMH, as well as at least one disc diameter of normal retina in all directions surrounding the SMH. In most cases, the detachment extended more peripherally, and the detachment was confirmed intraoperatively by the surgeon without the use of a hand-held OCT. A 50% to 75% air fill was performed in all subjects to aid in displacement of SMH. In all cases, the area of induced RD was completely reattached on clinical examination postoperative day 1. Subjects were seen for postoperative follow-up at 1 day, 1 week, and 1 month, and subsequently, at the discretion of the surgeon and based on medical need. No subjects required additional procedures and no recurrence of hemorrhage was noted.